|
Aug 6
|
BridgeBio Pharma Inc (BBIO) Q2 2025 Earnings Call Highlights: Record Revenue Surge and ...
|
|
Aug 5
|
BridgeBio Pharma (BBIO) Reports Q2 Loss, Beats Revenue Estimates
|
|
Aug 5
|
BridgeBio Pharma: Q2 Earnings Snapshot
|
|
Aug 5
|
BridgeBio Reports Second Quarter 2025 Financial Results and Business Updates
|
|
Jul 31
|
Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 30
|
Biotech Has Been Stalling. 3 Stocks That Could See Healthy Gains.
|
|
Jul 30
|
Peloton upgraded, Booking downgraded: Wall Street's top analyst calls
|
|
Jul 29
|
BridgeBio Pharma (BBIO) Expected to Beat Earnings Estimates: Should You Buy?
|
|
Jul 25
|
Truist Sees Upside in BridgeBio Pharma’s (BBIO) ATTR-CM Strategy
|
|
Jul 23
|
Novel Human Genetics Evidence Confirms Estimates of Genetic Prevalence, Underdiagnosis, and Potentially Greater Symptom Burden of Gain-of-Function CASR Variants Associated with ADH1
|
|
Jul 22
|
BridgeBio to Host Second Quarter 2025 Financial Results Conference Call on Tuesday, August 5, 2025 at 4:30 pm ET
|
|
Jul 16
|
These 2 Momentum Stocks Got a Bullish Nod — Here’s Why They Could Reach New Highs
|
|
Jul 14
|
Rivian downgraded, PayPal upgraded: Wall Street's top analyst calls
|
|
Jul 7
|
High Growth Tech Stocks To Watch In The US July 2025
|
|
Jul 6
|
BridgeBio Pharma Raises $300M Through Partial European Royalty Monetization for BEYONTTRA
|
|
Jul 2
|
BridgeBio (BBIO) Tanks After Selling Beyonttra Royalty Rights
|
|
Jun 30
|
BridgeBio Raises $300 Million Through Partial Capped Monetization of BEYONTTRA® European Royalty
|
|
Jun 26
|
BridgeBio to Host Limb-girdle Muscular Dystrophy Type 2I/R9 Investor Webinar on Friday, July 11th at 8:00 am ET
|
|
Jun 25
|
TipRanks’ ‘Perfect 10’ Picks: 2 Top-Scoring Stocks That Are Ticking Every Box
|
|
Jun 24
|
Piper Sandler Reaffirms Overweight Rating on BridgeBio Ahead of Phase 3 CALIBRATE Results
|